Value of pretherapeutic DWI in evaluating prognosis and therapeutic effect in immunocompetent patients with primary central nervous system lymphoma given high-dose methotrexate-based chemotherapy: ADC-based assessment

Zhang Y.; Zhang Q.; Wang X. -x.; Deng X. -f.; Zhu Y. -z.

首页> 外文期刊>Clinical Radiology: Journal of the Royal College of Radiologists >Value of pretherapeutic DWI in evaluating prognosis and therapeutic effect in immunocompetent patients with primary central nervous system lymphoma given high-dose methotrexate-based chemotherapy: ADC-based assessment

【24h】

Value of pretherapeutic DWI in evaluating prognosis and therapeutic effect in immunocompetent patients with primary central nervous system lymphoma given high-dose methotrexate-based chemotherapy: ADC-based assessment

机译：大剂量甲氨蝶呤为基础的大剂量氨甲蝶呤化疗后，治疗前DWI对免疫原发性中枢神经系统淋巴瘤患者评估预后和治疗价值的价值：基于ADC的评估

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

AIM: To investigate apparent diffusion coefficient (ADC) as a prognostic indicator in primary central nervous system lymphoma (PCNSL) by analysing patient clinical characteristics and pretherapeutic diffusion-weighted imaging (DWI).

机译：目的：通过分析患者的临床特征和治疗前扩散加权成像（DWI），研究表观扩散系数（ADC）作为原发性中枢神经系统淋巴瘤（PCNSL）的预后指标。

著录项

来源
《Clinical Radiology: Journal of the Royal College of Radiologists》 |2016年第10期|共12页
作者
Zhang Y.; Zhang Q.; Wang X. -x.; Deng X. -f.; Zhu Y. -z.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Value of pretherapeutic DWI in evaluating prognosis and therapeutic effect in immunocompetent patients with primary central nervous system lymphoma given high-dose methotrexate-based chemotherapy: ADC-based assessment [J] . Zhang Y., Zhang Q., Wang X. -x., Clinical Radiology: Journal of the Royal College of Radiologists . 2016,第10期

机译：大剂量甲氨蝶呤为基础的大剂量氨甲蝶呤化疗后，治疗前DWI对免疫原发性中枢神经系统淋巴瘤患者评估预后和治疗价值的价值：基于ADC的评估
2. Contrast-Enhanced MRI Texture Parameters as Potential Prognostic Factors for Primary Central Nervous System Lymphoma Patients Receiving High-Dose Methotrexate-Based Chemotherapy [J] . Chaoyue Chen, Hongyu Zhuo, Xiawei Wei, Contrast media & molecular imaging . 2019,第1期

机译：对比度增强的MRI纹理参数作为接受高剂量甲氨蝶呤化疗的原发性中枢神经系统淋巴瘤患者的潜在预后因素
3. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. [J] . Poortmans PM, Kluin Nelemans HC, Haaxma Reiche H, Journal of Clinical Oncology . 2003,第24期

机译：基于大剂量甲氨蝶呤的化学疗法，然后在非艾滋病相关的原发性中枢神经系统淋巴瘤中合并放疗：欧洲癌症淋巴瘤研究与治疗组织第二阶段试验20962。
4. Optical properties of the chemotherapy drugs used in the central nervous system lymphoma therapy: monitoring drug delivery [C] . T. Myllylae, A. Popov, L. Surazynski, Novel Biophotonics Techniques and Applications III . 2015

机译：用于中枢神经系统淋巴瘤治疗的化学疗法药物的光学性质：监测药物输送
5. Utility of apparent diffusion coefficients in the evaluation of primary central nervous system lymphoma. [D] . Gilbert, John Webster. 2012

机译：表观扩散系数在原发性中枢神经系统淋巴瘤评估中的应用。
6. Contrast-Enhanced MRI Texture Parameters as Potential Prognostic Factors for Primary Central Nervous System Lymphoma Patients Receiving High-Dose Methotrexate-Based Chemotherapy [O] . Chaoyue Chen, Hongyu Zhuo, Xiawei Wei, 2019

机译：造影剂增强的MRI纹理参数作为原发中枢神经系统淋巴瘤接受大剂量甲氨蝶呤化疗的潜在预后因素
7. Therapeutic Outcomes and Toxicity of High-Dose Methotrexate-Based Chemotherapy for Elderly Patients with Primary Central Nervous System Lymphoma: A Report on Six Cases [O] . Akira Tempaku, Yoshinobu Takahashi, Hajime Kamada 2019

机译：高剂量甲氨蝶呤化疗对老年中枢神经系统淋巴瘤患者的治疗结果和毒性：6例报告

Value of pretherapeutic DWI in evaluating prognosis and therapeutic effect in immunocompetent patients with primary central nervous system lymphoma given high-dose methotrexate-based chemotherapy: ADC-based assessment

摘要

著录项

相似文献

相关主题

期刊订阅